In a groundbreaking move within the decentralized finance (DeFi) sector, Hyperion DeFi, Inc. has entered into its inaugural HYPE Asset Use Service (HAUS) agreement with the proprietary trading firm Credo Cayman. This strategic partnership is designed to leverage the potential of Hyperliquid’s native token, HYPE, to enhance trading efficiency and reduce costs.
Under the terms of this unique on-chain agreement, Hyperion DeFi will provide Credo with access to 100,000 staked HYPE tokens. This arrangement aims to lower transaction fees associated with trading on the Hyperliquid platform, which can benefit both parties as the resultant fee savings will be distributed between Hyperion DeFi and Credo, establishing a new revenue stream for both companies.
Hyunsu Jung, the Interim Chief Executive Officer of Hyperion DeFi, emphasized the significance of this agreement, stating that it showcases the company’s capability to tap into novel revenue-generating opportunities that are made possible through decentralized finance. Jung described this deal as a critical step in Hyperion DeFi’s long-term objective to drive more financial activities onto the Hyperliquid platform.
Credo Cayman, which is known for its expertise in both traditional and digital asset markets, stands to gain considerable advantages from the partnership. The trading firm, which previously concentrated on centralized exchanges like Coinbase and Binance, will now take advantage of Hyperliquid’s reduced fees and competitive trade settlement times. The firm is staffed by seasoned traders and technologists, bringing years of experience to this innovative collaboration.
The Hyperliquid platform itself is distinguished as a layer one blockchain that focuses on high-frequency trading while maintaining transparency. Its architecture supports fully on-chain perpetual futures and spot order books, enabling rapid order processing with block times of just 70 milliseconds. The platform also features the HyperEVM, which facilitates permissionless decentralized applications much like Ethereum.
The native token HYPE not only represents a currency within the Hyperliquid ecosystem but also delivers additional user benefits through reduced trading fees and referral bonuses. Notably, a mechanism is in place that autonomously purchases and sequesters HYPE using trading fees generated from the network’s order books, with over 30 million tokens already sequestered, positioning HYPE as the 16th-largest cryptocurrency by market capitalization as of September 2025.
Hyperion DeFi aims to make HYPE an accessible asset for its shareholders, offering simple entry into the rapidly expanding Hyperliquid ecosystem. The company’s model is rooted in providing a sustained yield from staking, alongside revenues produced by its on-chain services.
In addition to its activities in the DeFi space, Hyperion DeFi is also involved in developing a proprietary medical device called the Optejet User Filled Device (UFD). This device is designed to administer topical ophthalmic treatments, potentially improving patient compliance and outcomes for chronic eye conditions.
Both Hyperion DeFi and Credo Cayman see this partnership as a pivotal step that could redefine trading dynamics in the decentralized finance landscape. As both companies expand their collaborative efforts and explore further innovative opportunities, the implications for the DeFi market could be significant.
